Compared with CD5- cases, CD5+ DLBCL cases showed more frequent IRF4/MUM1 (p = 0.038), BCL2 (p = 0.003), and MYC (p<0.001) expression and a higher Ki-67 proliferation index (p = 0.007). Here, MYC is linked to diffuse large B-cell lymphoma.